Some people who have Alzheimer’s disease pathology never get dementia because they have a protective biological mechanism working in their favor, a new study suggests.

In February, the Cancer Prevention and Research Institute of Texas awarded Dr. Ana M. Rodriguez and her research team a $2.26 million grant to help fight human papillomavirus related cancers. Texas has one of the lowest HPV vaccination rates in the country, and in the Rio Grande Valley, young people are at a higher risk of developing HPV-related cancers.

Thomas Smith, professor of biochemistry and molecular biology at the University of Texas Medical Branch in Galveston, is among the 508 scientists, engineers and innovators who have been elected 2022 AAAS Fellows for their scientifically and socially distinguished achievements throughout their careers.

The University of Texas Medical Branch is in the top 2 percent of research institutions receiving funding from the National Institutes of Health moving up in the latest rankings released by the Blue Ridge Institute for Medical Research.

Imagine if one test could tell you if you were protected from the latest COVID-19 variant. A partnership between state-of-the-art robotics and cutting-edge medical research will allow doctors at the University of Texas Medical Branch (UTMB) to give their patients more personalized and useful information.

University of Texas Medical Branch researcher Dr. Shannon Guillot-Wright was recently awarded a $660,000 grant from the Centers for Disease Control to fund a five-year research project to address health disparities for commercial fishermen.

UTMB has been awarded an agreement up to nearly $25 million from the U.S. Department of Defense’s (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) (within the Administration for Strategic Preparedness and Response (ASPR)), for their efforts in the collaborative development of vaccines to protect against infection by Ebola (EBOV), Sudan (SUDV), Marburg (MARV), and Lassa (LASV) viruses. This project award was executed via Other Transaction Authority (OTA) to UTMB through the Medical CBRN Defense Consortium (MCDC).

The University of Texas Medical Branch (UTMB) has been awarded a project agreement worth up to $87.4 million by the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response (ASPR), through the Medical CBRN Defense Consortium (MCDC) Other Transaction Authority (OTA), for the development of a vaccine technology against advanced and emerging viral threats. Two deadly viruses of significance to military personnel will be targeted for vaccine protection. These are Crimean-Congo hemorrhagic fever virus (CCHFV) and Nipah virus (NiV).

Researchers at the University of Texas Medical Branch have developed a way to study gestational disease thanks to a breakthrough that mimics pregnancy using miniature organ models made up of human cells embedded onto silicon surfaces.

The Royal Microscopical Society (RMS) has awarded Dr. Michael P. Sheetz the Pearse Prize for his “long and illustrious career in mechanobiological research”.